<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns:ifp="http://www.ifactory.com/press" xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9">
  <ifp:contentType>ARTICLE</ifp:contentType>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/11/3/article-p229.xml</sm:loc>
    <ifp:title>Keeping Cancer Patients Out of the Hospital at the End of Life</ifp:title>
    <sm:lastmod>2019-01-02</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/11/3/article-p232.xml</sm:loc>
    <ifp:title>In Chemotherapy for Lung Cancer, Sometimes Less is More</ifp:title>
    <sm:lastmod>2019-01-02</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/11/3/article-p240.xml</sm:loc>
    <ifp:title>Part 1: Abstracts From the NCCN 18th Annual Conference: Advancing the Standard of Cancer Care™</ifp:title>
    <sm:lastmod>2019-01-02</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/11/3/article-p246.xml</sm:loc>
    <ifp:title>Adjuvant Chemotherapy Decisions in Clinical Practice for Early-Stage Node-Negative, Estrogen Receptor-Positive, HER2-Negative Breast Cancer: Challenges and Considerations</ifp:title>
    <sm:lastmod>2019-01-02</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/11/3/article-p257.xml</sm:loc>
    <ifp:title>Non-Hodgkin’s Lymphomas, Version 1.2013</ifp:title>
    <sm:lastmod>2019-01-02</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/11/3/article-p275.xml</sm:loc>
    <ifp:title>Cutaneous T-Cell Lymphoma in Sub-Saharan Africa</ifp:title>
    <sm:lastmod>2019-01-02</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/11/3/article-p281.xml</sm:loc>
    <ifp:title>Point: Impact of Prostate-Specific Antigen Velocity on Management Decisions and Recommendations</ifp:title>
    <sm:lastmod>2019-01-02</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/11/3/article-p286.xml</sm:loc>
    <ifp:title>Counterpoint: Prostate-Specific Antigen Velocity Is Not of Value for Early Detection of Cancer</ifp:title>
    <sm:lastmod>2019-01-02</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/11/3/article-p298.xml</sm:loc>
    <ifp:title>Optimizing Neoadjuvant Therapy for Rectal Cancer With Oxaliplatin</ifp:title>
    <sm:lastmod>2019-01-02</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/11/3/article-p308.xml</sm:loc>
    <ifp:title>Maintenance Therapy With Tyrosine Kinase Inhibitors After Transplant in Patients With Chronic Myeloid Leukemia</ifp:title>
    <sm:lastmod>2019-01-02</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/11/3/article-p320.xml</sm:loc>
    <ifp:title>Cervical Cancer</ifp:title>
    <sm:lastmod>2019-01-02</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/11/3/article-p348.xml</sm:loc>
    <ifp:title>What Is the Appropriate Approach to Treating Women With Incurable Cervical Cancer?</ifp:title>
    <sm:lastmod>2019-01-02</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/11/3/article-p357.xml</sm:loc>
    <ifp:title>A Perspective on Dose Banding</ifp:title>
    <sm:lastmod>2019-01-02</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/11/3/article-pxii.xml</sm:loc>
    <ifp:title>NCCN News</ifp:title>
    <sm:lastmod>2019-01-02</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/11/3/article-pxxi.xml</sm:loc>
    <ifp:title>Oncology Research Program</ifp:title>
    <sm:lastmod>2019-01-02</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/11/3/article-pxxiii.xml</sm:loc>
    <ifp:title>JNCCN CE Offerings</ifp:title>
    <sm:lastmod>2019-01-02</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/11/suppl_1/article-pS-1.xml</sm:loc>
    <ifp:title>Optimal Cancer Care: Concurrent Oncology and Palliative Care</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/11/suppl_1/article-pS-3.xml</sm:loc>
    <ifp:title>Early Implementation of Palliative Care Can Improve Patient Outcomes</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/11/suppl_1/article-pS-11.xml</sm:loc>
    <ifp:title>Barriers and Approaches to the Successful Integration of Palliative Care and Oncology Practice</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/11/suppl_1/article-pS-17.xml</sm:loc>
    <ifp:title>Provision of Palliative Care and Pain Management Services for Oncology Patients</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/11/suppl_1/article-pS-29.xml</sm:loc>
    <ifp:title>Guidelines for the Management of Breakthrough Pain in Patients With Cancer</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/11/suppl_1/article-pS-37.xml</sm:loc>
    <ifp:title>Evidence-Based Treatment of Cancer-Related Breakthrough Pain With Opioids</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
</urlset>
